Skip to content

Evaluation of efficacy and safety of Unani formulation in Acne

Clinical evaluation of Unani formulations in the management of Busoor Labaniyah (Acne vulgaris). - CEUFMAV

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009004
Enrollment
60
Registered
2017-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acne Vulgaris

Interventions

Intervention1: Unani formulation- Zimad-e-Muhasa & Cap. Shahatra: Topical:- Zimad-e-Muhasa to be applied as paste once daily. Oral:- Cap. Shahtra 2 BD (Dried aqueous extract of 5g of Barg-e-Shahtra

Sponsors

Dept of Moalajat Jamia Hamdard
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with moderate to severe acne (score of acne 19-38), as per the Global Acne Grading System (GAGS).

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. Patients using hormonal contraceptives. Patients suffering from PCOD. Patients suffering from other concomitant skin diseases. Patients having liver & renal diseases. Patients using drugs known to be photo sensitizers and anti-androgenic drugs. Patients who have used topical anti-acne medications within the past two weeks. Patients who have used systemic antibiotic within past one month. Patients who have used isotretinoin in the last six months. Patients using medications that are reported to exacerbate acne. Patients have had chemical or laser peel & artificial UV therapy.

Design outcomes

Primary

MeasureTime frame
GAGS Scale (Global Acne Grading System).Timepoint: 0 Day, 14th Day, 28th Day, 42nd Day, 56th Day

Secondary

MeasureTime frame
Coloured photographs of the lesion with the same magnification. Timepoint: 0 Day & 56th Day;Likert scale: Itching, erythema & scaring will be assessed on likert scale (0-3)Timepoint: 0 Day, 14th Day, 28th Day, 42nd Day, 56th Day;safety parameters include (CBC with ESR, LFT, KFT, U-R/MTimepoint: 0 Day & 56th Day ;The Cardiff Acne Disability Index - to assess quality of lifeTimepoint: 0 Day, 28th Day, 56th Day

Countries

India

Contacts

Public ContactDr Umar Jahangir

Jamia Hamdard

yshamsi@jamiahamdard.ac.in8750040776

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026